
Former "Bachelorette" JoJo Fletcher and her husband, Jordan Rodgers, welcomed their first baby via emergency cesarean section days before Christmas, the couple announced.
Fletcher wrote on Instagram that she went for a sonogram appointment on Tuesday and "found out we needed to deliver via emergency c section that day."
Their baby girl, Romy Blair Rodgers, was born at 5:37 p.m. on Tuesday.
Prince William, Kate Middleton and kids spread cheer on Christmas
"What a whirlwind these last couple of days have been but in the most magical way," she wrote.
"Merry Christmas to us," she said.
How celebrities are celebrating Christmas 2025
Fletcher's best friend from "The Bachelor," Becca Tilley, commented, "Our little Romy girl!!!!! Love y’all so much! So proud of you!!!!!"
Rodgers, a college football analyst, won Fletcher's final rose on season 12 of the "Bachelorette," which aired in 2016. They tied the knot in 2022. Fletcher announced her pregnancy in August, saying they were welcoming a "rainbow baby."
latest_posts
- 1
Analysis-From 'Icarus bug' to flawed panels: Airbus counts cost of relying on single model - 2
Ariana Grande says Eternal Sunshine 2026 tour will be her last for a 'long, long time': 'One last hurrah' - 3
Could it be said that you are As yet Utilizing Old Tires? at These 6 Tire Brands - 4
How to watch the 2025 Macy's Thanksgiving Day Parade for free - 5
Manual for Individual accounting Rudiments for Fledglings
5 Language Learning Applications
Steven Spielberg's 'Disclosure Day' trailer drops: What we know about the alien movie
Astonishing Deserts All over The Planet You Really want To Visit
'Stranger Things' Season 5: When does Volume 2 come out? And Volume 3? Everything to know about the remaining episodes before the finale.
vote in favor of Your #1 kind of climate
Astronomers spot white dwarf star creating a colorful shockwave
Audits of the Top Science fiction Movies This Year
Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug












